MKH Capital Partners acquires Haven Health Management
MKH Capital Partners has acquired Haven Health Management, a provider in the mental health and substance use disorder (SUD) sector, for $100 million. This transaction underscores MKH's interest in the behavioral health space, with Haven operating 22 locations across nine states and Puerto Rico. The acquisition includes Haven's brands such as Indiana Center for Recovery, The Haven Detox, and The Recovery Team, which offer comprehensive treatment services ranging from medical detox to outpatient programs.
The purchase also encompasses United Billing Solutions, a billing organization focused on behavioral health. This will bolster Haven's capabilities in managing in-network billing and potentially expand its insurance partnerships. MKH Capital Partners, whose portfolio spans fertility services to security services, aims to foster further growth at Haven, maintaining its current quality and industry standing while exploring new geographic and service expansion under new leadership. Brian Thorn, veteran in the SUD field, takes the helm as CEO, bringing prior leadership experience from Pinnacle Treatment Centers and Foundations Recovery Network.
MKH has articulated a strategic vision to broaden Haven’s market reach through expanded health insurance connections and new openings under the Haven Detox brand. Miguel Heras, founder of MKH Capital Partners, highlighted Haven’s established credentials and expects the firm to support its continued growth without losing its distinctive attributes.
This acquisition occurs against a backdrop of renewed activity in the behavioral health M&A market, where asset prices are slowly aligning with investor expectations. The earlier standoff between high seller price demands and buyer caution seems to be easing, propelled by substantial undeployed capital reserves among institutional investors. This dynamic sets the stage for considerable dealmaking potential, especially for significant platforms like Haven, amid a recalibrating post-COVID valuation climate.
Looking ahead, the focus will be on how regulatory approvals unfold and how quickly Haven can implement its strategy for expansion under new leadership. The deal also suggests a potential shift in the sector's investment climate as stakeholders reassess valuations and capital allocation in behavioral health.
Deal timeline
This transaction is classified in Mental Health and Substance Use Disorder with a reported deal value of $100M. Figures and status may change as sources update.